Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Perspective Therapeutics (CATX) over the last 14 years, with Q4 2024 value amounting to $4.0 million.

  • Perspective Therapeutics' Non-cash Items fell 9994.0% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 million, marking a year-over-year decrease of 9994.0%. This contributed to the annual value of $4.0 million for FY2024, which is 8873.12% down from last year.
  • Perspective Therapeutics' Non-cash Items amounted to $4.0 million in Q4 2024, which was down 9994.0% from $6.7 billion recorded in Q4 2023.
  • In the past 5 years, Perspective Therapeutics' Non-cash Items registered a high of $6.7 billion during Q4 2023, and its lowest value of $2000.0 during Q2 2022.
  • For the 5-year period, Perspective Therapeutics' Non-cash Items averaged around $517.9 million, with its median value being $984000.0 (2021).
  • As far as peak fluctuations go, Perspective Therapeutics' Non-cash Items surged by 68520000.0% in 2023, and later crashed by 9994.0% in 2024.
  • Perspective Therapeutics' Non-cash Items (Quarter) stood at $23000.0 in 2020, then skyrocketed by 17552.17% to $4.1 million in 2021, then plummeted by 99.95% to $2000.0 in 2022, then soared by 333562650.0% to $6.7 billion in 2023, then tumbled by 99.94% to $4.0 million in 2024.
  • Its Non-cash Items stands at $4.0 million for Q4 2024, versus $6.7 billion for Q4 2023 and $2.3 million for Q3 2023.